Market Research Logo

Kyowa Hakko Kirin Co Ltd (4151) - Financial and Strategic SWOT Analysis Review

Kyowa Hakko Kirin Co Ltd (4151) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Kyowa Hakko Kirin Co Ltd (Kyowa Hakko), a subsidiary of Kirin Holdings Company Limited, is a research and development (R&D) based biotechnology company. It focuses on the discovery, development, production and commercialization of pharmaceuticals and biotechnology products. The company offers drugs in the areas of nephrology, oncology, immunology and allergy, central nervous system among others. Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and others. The company operates through a network of subsidiaries in the US, Europe and Asia. Kyowa Hakko is headquartered in Tokyo, Japan.

Kyowa Hakko Kirin Co Ltd Key Recent Developments

Mar 22,2018: Kyowa Hakko Kirin and BioWa Obtain Successful Settlement of United States Patent Infringement Lawsuit against Aragen Bioscience and Transposagen
Feb 08,2018: Kyowa Hakko Kirin: Announcement of Consolidated Financial Results Fiscal 2017
Jan 29,2018: Kyowa Hakko Kirin Announces the Establishment of a Regional Headquarters Function for the Asia and Oceania Region in Singapore
Jan 04,2018: Kyowa Hakko Kirin: Notice of completion of domestic production base reorganization
Dec 22,2017: Kyowa Hakko Kirin Announces Changes in the Representative Directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Kyowa Hakko Kirin Co Ltd - Key Facts
Kyowa Hakko Kirin Co Ltd - Key Employees
Kyowa Hakko Kirin Co Ltd - Key Employee Biographies
Kyowa Hakko Kirin Co Ltd - Major Products and Services
Kyowa Hakko Kirin Co Ltd - History
Kyowa Hakko Kirin Co Ltd - Company Statement
Kyowa Hakko Kirin Co Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Kyowa Hakko Kirin Co Ltd - Business Description
Business Segment: Bio-Chemicals
Overview
Performance
Business Segment: Pharmaceuticals
Overview
Performance
Geographical Segment: Americas
Performance
Geographical Segment: Asia
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Japan
Performance
Geographical Segment: Overseas
Performance
R&D Overview
Kyowa Hakko Kirin Co Ltd - SWOT Analysis
SWOT Analysis - Overview
Kyowa Hakko Kirin Co Ltd - Strengths
Kyowa Hakko Kirin Co Ltd - Weaknesses
Kyowa Hakko Kirin Co Ltd - Opportunities
Kyowa Hakko Kirin Co Ltd - Threats
Kyowa Hakko Kirin Co Ltd - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Kyowa Hakko Kirin Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Kyowa Hakko Kirin Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Kyowa Hakko Kirin Co Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 22, 2018: Kyowa Hakko Kirin and BioWa Obtain Successful Settlement of United States Patent Infringement Lawsuit against Aragen Bioscience and Transposagen
Feb 08, 2018: Kyowa Hakko Kirin: Announcement of Consolidated Financial Results Fiscal 2017
Jan 29, 2018: Kyowa Hakko Kirin Announces the Establishment of a Regional Headquarters Function for the Asia and Oceania Region in Singapore
Jan 04, 2018: Kyowa Hakko Kirin: Notice of completion of domestic production base reorganization
Dec 22, 2017: Kyowa Hakko Kirin Announces Changes in the Representative Directors
Dec 01, 2017: Faron Pharmaceuticals Oy: Appointment of Chief Commercial Officer
Oct 26, 2017: Kyowa Hakko Kirin: Fiscal 2017 Third Quarter Results
Sep 28, 2017: Kyowa Hakko Kirin: Financial results for Six Months Ended June 30, 2017
Mar 09, 2017: Results from Studies using PXB-Mouse being presented at ToxExpo 2017
Jan 31, 2017: Kyowa Hakko Kirin Establishes Kyowa Kirin Frontier
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Kyowa Hakko Kirin Co Ltd, Key Facts
Kyowa Hakko Kirin Co Ltd, Key Employees
Kyowa Hakko Kirin Co Ltd, Key Employee Biographies
Kyowa Hakko Kirin Co Ltd, Major Products and Services
Kyowa Hakko Kirin Co Ltd, History
Kyowa Hakko Kirin Co Ltd, Other Locations
Kyowa Hakko Kirin Co Ltd, Subsidiaries
Kyowa Hakko Kirin Co Ltd, Joint Venture
Kyowa Hakko Kirin Co Ltd, Key Competitors
Kyowa Hakko Kirin Co Ltd, Ratios based on current share price
Kyowa Hakko Kirin Co Ltd, Annual Ratios
Kyowa Hakko Kirin Co Ltd, Annual Ratios (Cont...1)
Kyowa Hakko Kirin Co Ltd, Annual Ratios (Cont...2)
Kyowa Hakko Kirin Co Ltd, Interim Ratios
Kyowa Hakko Kirin Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Kyowa Hakko Kirin Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Kyowa Hakko Kirin Co Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Kyowa Hakko Kirin Co Ltd, Performance Chart (2013 - 2017)
Kyowa Hakko Kirin Co Ltd, Ratio Charts
Kyowa Hakko Kirin Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Kyowa Hakko Kirin Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report